Skip to main content

Market Overview

Xeris Pharmaceuticals, Inc. (XERS)

4.08 -0.08 (-1.92%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/23/20MizuhoMaintainsBuy14.0
2/20/20MizuhoMaintainsBuy18.0
2/18/20Piper SandlerInitiates Coverage OnOverweight12.0
9/11/19MizuhoMaintainsBuy22.0
7/17/18MizuhoInitiates Coverage OnBuy26.0
7/16/18Leerink SwannInitiates Coverage OnOutperform24.0
7/16/18RBC CapitalInitiates Coverage OnOutperform24.0
7/16/18JefferiesInitiates Coverage OnBuy23.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter